Skip to main content

Table 1 Sample summary table presented in survey showing select results from overview of reviews on bronchiolitis

From: An evaluation of harvest plots to display results of meta-analyses in overviews of reviews: a cross-sectional study

Bronchiolitis - inpatient outcomes
Clinical score Length of stay
Time point for clinical score assessment Patients (studies) Effect estimate SMD (95 % CI) I2 (%) Quality of evidence Patients (studies) Effect estimate MD (95 % CI) I2 (%) Quality of evidence
Glucocorticoids vs. placebo
 At 1–3 days 113 (4) −0.74 (−1.48,1.01) 70 Low 633 (8) −0.18 (−0.39,0.04) 16 High
Bronchodilator vs. placebo
 No data 349 (6) 0.06 (−0.27,0.39) 0 Moderate
Epinephrine vs. placebo
 At 60 min 232 (2) −0.04 (−0.49, 0.40) 46 Moderate 292 (2) −0.35 (−0.87,0.17) 0 Moderate
Epinephrine vs. bronchodilator
 At 60 min 248 (4) −0.79 (−1.45,-0.13) a 79 Low 261 (4) −0.28 (−0.46,-0.09) a 0 Moderate
 At 120 min 140 (1) −0.52 (−0.68,-0.18) a NA Low
3 % hypertonic saline vs. 0.9 % saline
 At 1–3 days 183 (3) −0.84 (−1.39,-0.30) 66 Low 282 (4) −1.16 (−1.55,-0.77) a 0 Moderate
 At 3–10 days 156 (3) −1.08 (−2.47,0.31) 93 Moderate
Chest physiotherapy vs. standard care or other drainage/breathing technique
 At 1–3 days 87 (1) −0.55 (−0.98,-0.12) a NA Low 172 (3) 0.07 (−0.58,0.73) 0 Low
 At 3–10 days 91 (2) −0.14 (−0.81,0.53) 59 Low
  1. afavours 1st intervention; NA - not applicable; SMD - standardized mean difference
  2. Outcomes in bold indicate statistical significance